Phase 4 Age-Related Macular Degeneration Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Genentech, Inc.188 enrolled50 locationsNCT04853251
Recruiting
Phase 4
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc20 enrolled16 locationsNCT06970665
Recruiting
Phase 4
Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment
Age-related Macular Degeneration (ARMD)
Kim's Eye Hospital40 enrolled1 locationNCT06683950
Not Yet Recruiting
Phase 4
Assessing the Efficacy and Durability of Faricimab in Patients Currently Treated for Neovascular Age-Related Macular Degeneration.
Neovascular Age-related Macular Degeneration
CUREOS150 enrolled1 locationACTRN12623000215628